Advanced search
Publication Cover
Current Medical Research and Opinion Volume 30, 2014 - Issue 8
Submit an article Journal homepage
2,176
Views
13
CrossRef citations to date
0
Altmetric
Brief report

Use of prescription opioids with abuse-deterrent technology to address opioid abuse

Edward MichnaBrigham and Women’s Hospital Chestnut Hill, MAUSA
,
Noam Y. KirsonAnalysis Group Inc. Boston, MAUSACorrespondence[email protected]
,
Amie SheiAnalysis Group Inc. Boston, MAUSA
,
Howard G. BirnbaumAnalysis Group Inc. Boston, MAUSA
&
Rami Ben-JosephPurdue Pharma LP Stamford, CTUSA
Pages 1589-1598 | Accepted 14 Apr 2014, Published online: 24 Apr 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Joseph V. Pergolizzi$suffix/text()$suffix/text(), Robert B. Raffa, Robert Taylor$suffix/text()$suffix/text() & Steven Vacalis. (2018) Abuse-deterrent opioids: an update on current approaches and considerations. Current Medical Research and Opinion 34:4, pages 711-723.
Read now
Carl L. Roland, Joanita Lake & Gary M. Oderda. (2016) Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 30:4, pages 258-268.
Read now

Articles from other publishers (11)

Jessica L. Taylor & Jeffrey H. Samet. (2022) Opioid Use Disorder. Annals of Internal Medicine 175:1, pages ITC1-ITC16.
Crossref
Michael DiNardi. (2021) The release of abuse-deterrent OxyContin and adolescent heroin use. Drug and Alcohol Dependence 229, pages 109114.
Crossref
Ronak Savla & Julien Meissonnier. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery 73 94 .
Amy Peacock, Briony Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A. Buckley, Michael Farrell & Louisa Degenhardt. (2019) Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting. Addiction 114:3, pages 389-399.
Crossref
Amit Garg, Vassiliki Papagermanos, Margaretta Midura, Andrew Strunk & Jonathan Merson. (2018) Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States. Journal of the American Academy of Dermatology 79:3, pages 495-500.e1.
Crossref
Howard D. Chilcoat, Paul M. Coplan, Venkatesh Harikrishnan & Louis Alexander. (2016) Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin). Drug and Alcohol Dependence 165, pages 221-228.
Crossref
Amie Shei, J. Bradford Rice, Noam Y. Kirson, Katharine Bodnar, Caroline J. Enloe, Howard G. Birnbaum, Pamela Holly & Rami Ben-Joseph. (2015) Characteristics of High-Cost Patients Diagnosed with Opioid Abuse. Journal of Managed Care & Specialty Pharmacy 21:10, pages 902-912.
Crossref
Xiulu Ruan & Alan D. Kaye. (2015) Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety. Therapeutic Advances in Drug Safety 6:5, pages 196-197.
Crossref
Noam Y. Kirson, Amie Shei, J. Bradford Rice, Caroline J. Enloe, Katharine Bodnar, Howard G. Birnbaum, Pamela Holly & Rami Ben-Joseph. (2015) The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals. Pain Medicine 16:7, pages 1325-1332.
Crossref
Harry J. GouldIIIIII & Dennis Paul. (2015) Hydrocodone extended-release: Pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy. Pharmacological Research 91, pages 99-103.
Crossref
Noam Y. Kirson, Amie Shei, Alan G. White, Howard G. Birnbaum, Rami Ben-Joseph, Louis F. Rossiter & Edward Michna. (2014) Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States. Pain Medicine 15:9, pages 1450-1454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.